Clinical Trials in New York

Showing 11441-11460 of 22,668 trials

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT02129647

The purpose of this study is to determine if the study drug, AXITINIB, has any effect on tumors found in patients with Neurofibromatosis Type 2 (NF2).

Neurofibromatosis Type 2Vestibular Schwannomas

NYU Langone Health13 participantsStarted Apr 2014

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

NCT03430895

This study is being done test to test the safety and effectiveness of durvalumab combined with tremelimumab in patients who have a rare form of cancer of the urinary tract.

Non-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more

Memorial Sloan Kettering Cancer Center15 participantsStarted Jan 2018

Basking Ridge, New Jersey, United States • Commack, New York, United States • Harrison, New York, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Hematopoietic cell transplants (HCT)are one treatment option for people with leukemia or lymphoma. Family members,unrelated donors or banked umbilical cordblood units with similar tissue type can be used for HCT. This study will compare the effectiveness of two new types of bone marrow transplants in people with leukemia or lymphoma: one that uses bone marrow donated from family members with only partially matched bone marrow; and, one that uses two partially matched cord blood units.

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaBurkitt's Lymphoma+4 more

Medical College of Wisconsin368 participantsStarted Jun 2012

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Duarte, California, United States +36 more locations

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Double Cord Versus Haploidentical (BMT CTN 1101)

Find Trials by Condition in New York

CoolSculpting of the Distal Thigh Study

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Study for the RevLite Laser System for Facial Solar Lentigines

A Study of Brain Aging in Vietnam War Veterans

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial

Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma